Humacyte investor relations material

Listen to the latest call from Humacyte

Humacyte, Inc. engages in developing, manufacturing and commercializing products for off-the-shelf therapy. The company focuses on solid tumors, benign bone growths, and vascular disease. It also manufactures human tissue for other therapies. The company was founded in 2004 and is headquartered in Durham, North Carolina.

  • Ticker

  • Country


Dig deeper into the Humacyte fundamentals on Quartr.